Literature DB >> 20973824

Kidney from uncontrolled donors after cardiac death with one hour warm ischemic time: resuscitation by extracorporal normothermic abdominal perfusion "in situ" by leukocytes-free oxygenated blood.

Oleg Reznik1, Andrej Skvortsov, Igor Loginov, Alexey Ananyev, Sergey Bagnenko, Yan Moysyuk.   

Abstract

The availability of brain death donors is restricted by many factors. Use of uncontrolled donors after cardiac death could be a promising perspective, but the limiting factor in uncontrolled donation after cardiac death is the warm ischemic time. The purpose of our work was to develop an in situ kidney preservation protocol with application of the extracorporal normothermic abdominal perfusion for organ resuscitation in uncontrolled donors after cardiac death. The main attention was paid to the elimination of leukocytes as the key damaging factor from modified donor oxygenated blood circulating in the device. In 2009, we had 10 uncontrolled donors with warm ischemic time from 45 to 92 min; a normothermic extracorporal perfusion device was applied, providing preservation and restoration of kidney after ischemic damage. In 6 out of 20 kidney recipients, graft function was recovered immediately. All kidney grafts are functioning, and to the end of the third month, the average creatinine was 118.5 ± 19.9 mM. Treatment of ischemically damaged kidney by normothermic extracorporal perfusion with leukocyte depletion before procurement seems to be a challenging protocol for expanding donors' pool and demands further study.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20973824     DOI: 10.1111/j.1399-0012.2010.01333.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  7 in total

Review 1.  Kidney donation after cardiac death.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2012-06-06

2.  Successful Porcine Renal Transplantation After 60 Minutes of Donor Warm Ischemia: Extracorporeal Perfusion and Thrombolytics.

Authors:  David S Demos; Amit Iyengar; Benjamin S Bryner; Brian W Gray; Hayley R Hoffman; Marie S Cornell; John E Wilkinson; Daniel E Mazur; Robert H Bartlett; Jeffrey D Punch; Alvaro Rojas-Peña
Journal:  ASAIO J       Date:  2015 Jul-Aug       Impact factor: 2.872

Review 3.  Machine perfusion in abdominal organ transplantation: Current use in the Netherlands.

Authors:  Elsaline Rijkse; Jan Nm IJzermans; Robert C Minnee
Journal:  World J Transplant       Date:  2020-01-18

4.  Canadian Guidelines for Controlled Pediatric Donation After Circulatory Determination of Death-Summary Report.

Authors:  Matthew J Weiss; Laura Hornby; Bram Rochwerg; Michael van Manen; Sonny Dhanani; V Ben Sivarajan; Amber Appleby; Mary Bennett; Daniel Buchman; Catherine Farrell; Aviva Goldberg; Rebecca Greenberg; Ram Singh; Thomas A Nakagawa; William Witteman; Jill Barter; Allon Beck; Kevin Coughlin; Alf Conradi; Cynthia Cupido; Rosanne Dawson; Anne Dipchand; Darren Freed; Karen Hornby; Valerie Langlois; Cheryl Mack; Meagan Mahoney; Deepak Manhas; Christopher Tomlinson; Samara Zavalkoff; Sam D Shemie
Journal:  Pediatr Crit Care Med       Date:  2017-11       Impact factor: 3.624

5.  A Single-center Experience of Kidney Transplantation from Donation after Circulatory Death: Challenges and Scope in India.

Authors:  S Singh; S Kumar; S Dasgupta; D B Kenwar; M Rathi; A Sharma; H S Kohli; V Jha; K L Gupta; M Minz
Journal:  Indian J Nephrol       Date:  2017 May-Jun

Review 6.  Donation after Circulatory Death in Paediatric Liver Transplantation: Current Status and Future Perspectives in the Machine Perfusion Era.

Authors:  Roberta Angelico; M Thamara P R Perera; Tommaso Maria Manzia; Alessandro Parente; Chiara Grimaldi; Marco Spada
Journal:  Biomed Res Int       Date:  2018-03-18       Impact factor: 3.411

7.  Systematic review to assess the possibility of return of cerebral and cardiac activity after normothermic regional perfusion for donors after circulatory death.

Authors:  I M Shapey; A Summers; T Augustine; D van Dellen
Journal:  Br J Surg       Date:  2019-01-22       Impact factor: 6.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.